about
Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant womenA new morphologically distinct avian malaria parasite that fails detection by established polymerase chain reaction-based protocols for amplification of the cytochrome B gene.Chronic infection. Hidden costs of infection: chronic malaria accelerates telomere degradation and senescence in wild birds.High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series.Primary peak and chronic malaria infection levels are correlated in experimentally infected great reed warblers.Cellular aging dynamics after acute malaria infection: A 12-month longitudinal study.Pale and dark morphs of tawny owls show different patterns of telomere dynamics in relation to disease status.Parallel telomere shortening in multiple body tissues owing to malaria infection.Skin pentosidine and telomere length do not covary with age in a long-lived seabird.Quantitative disease resistance: to better understand parasite-mediated selection on major histocompatibility complex.Co-infections by malaria parasites decrease feather growth but not feather quality in house martinAre chronic avian haemosporidian infections costly in wild birds?Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposurePregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine ConcentrationsImpact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosaUrothelial cell senescence is not linked with telomere shorteningPersistent transmission of Plasmodium malariae and Plasmodium ovale species in an area of declining Plasmodium falciparum transmission in eastern TanzaniaB cell profiling in malaria reveals expansion and remodelling of CD11c+ B cell subsets
P50
Q33869119-844662A1-708C-437D-8A58-FB6F36484BD6Q34144531-DA9119F3-CF71-4BB1-ABC7-7BA2E730A835Q35547625-D4FFCD49-ED14-469C-AE71-B3CDEB5198BDQ40406196-079F63FD-BF61-40C4-A541-601CF02F5F3EQ44924294-8394AB09-B47E-46B2-8970-D00B91C572AFQ48016744-B594CACE-BB0A-4651-AF6C-AAE1D88C8BCFQ51189790-9535A8D5-D914-41D1-967A-67F498159BE9Q51275429-FC813717-79DB-4441-BDDB-8349AFCC8571Q51369684-D61452C1-3EEB-45CD-BA0C-DF3A82BC858CQ51593866-F0FECA39-02C6-4946-A01F-6166F9370B33Q57414452-0A538C4C-7A84-4CBC-B650-BC93BF4043E2Q57414455-CF40AC6A-E0EB-4939-9ECA-FFFFB48EFB0BQ61805875-51E4B885-9BFE-42DC-BCC1-9EAE73673D39Q91343700-3BC1AC76-29FD-426E-804F-592808E06D88Q91620628-116CB5C4-8ED0-4D76-B069-3BF7CCA68AABQ92218556-3A784B1F-A692-446D-8FF0-8A8D13D01157Q92342917-1262B7E7-6469-4A26-8E57-2323D5EA94BDQ92786996-0E8B03DB-DF0B-4C2D-B78F-270177F01046
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Muhammad Asghar
@ast
Muhammad Asghar
@en
Muhammad Asghar
@es
Muhammad Asghar
@nl
Muhammad Asghar
@sl
type
label
Muhammad Asghar
@ast
Muhammad Asghar
@en
Muhammad Asghar
@es
Muhammad Asghar
@nl
Muhammad Asghar
@sl
prefLabel
Muhammad Asghar
@ast
Muhammad Asghar
@en
Muhammad Asghar
@es
Muhammad Asghar
@nl
Muhammad Asghar
@sl
P1053
C-6730-2013
P106
P1416
P31
P3829
P496
0000-0002-9017-2206